Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 3,638 | 2,462 | 2,306 | 1,669 | 2,356 |
| Operating Income | -3,638 | -2,462 | -2,306 | -1,669 | -2,356 |
| Other Income | 231 | 0 | -3 | -3 | 5 |
| Pre-tax Income | -3,407 | -2,462 | -2,309 | -1,672 | -2,351 |
| Net Income Continuous | -3,407 | -2,462 | -2,309 | -1,672 | -2,351 |
| Net Income | $-3,407 | $-2,462 | $-2,309 | $-1,672 | $-2,351 |
| EPS Basic Total Ops | -34.58 | 16.21 | -43.22 | -36.74 | -143.71 |
| EPS Basic Continuous Ops | -34.47 | 15.67 | -43.17 | -36.38 | -143.28 |
| EPS Diluted Total Ops | -34.58 | 16.21 | -43.22 | -36.74 | -143.71 |
| EPS Diluted Continuous Ops | -34.47 | 15.67 | -43.17 | -36.38 | -143.28 |
| EBITDA(a) | $-3,620 | $-2,445 | $-2,288 | $-1,650 | $-2,338 |